Page last updated: 2024-10-23

azathioprine and Cavernous Sinus Thrombophlebitis

azathioprine has been researched along with Cavernous Sinus Thrombophlebitis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Efthimiou, P1
Petryna, O1

Other Studies

1 other study available for azathioprine and Cavernous Sinus Thrombophlebitis

ArticleYear
Headache from cavernous sinus thrombosis in Adamantiades-Behçet disease.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2010, Volume: 16, Issue:8

    Topics: Adrenal Cortex Hormones; Azathioprine; Behcet Syndrome; Cavernous Sinus Thrombosis; Colchicine; Head

2010